Survey
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
Supplementary Table 1: Polymorphisms selected for possible genotyping of childhood acute lymphoblastic leukemia cases and controls Gene Polymorphism AA change MTR2 155G>A 2756A>G 2758C>G 66A>G 524C>T R52Q D919G H920D I22M S175L 4 MTRR 997C>G 1049A>G MTHFD15 TYMS6 SHMT110 RFC111 DHFR12 FOLR113 1243C>T 1783C>T 401C>T 1958G>A 2R3R7 1494del69 349T>C 470G>T 500C>T 1420C>T 80G>A 829C>T 82C>T 480G>C L333V K350R R415C H595Y K134R R653Q 28-bp repeats 6-bp deletion F117L G157V T167I L474F H127R 3’-UTR W28R W160C SNP id rs12749581 rs1805087 rs28933097 rs1801394 rs1532268 rs10064631 rs162036 rs2287780 rs10380 rs1950902 rs2236225 E3333-18 rs28365050 rs11540152 rs596909 rs11540153 rs1979277 rs1051266 rs7928649 rs1801932 MAF1 Source or Reference 0.01 0.13 0.48 0.36 0.24 0.09 0.17 0.25 0.01 0.19 0.20 0.45 0.50 0.40 0.38 0.50 0.16 0.05 - dbSNP (NCBI)3 1 dbSNP (NCBI) 1 2 2 dbSNP (NCBI) 2 dbSNP (NCBI) 2 dbSNP (NCBI) dbSNP (NCBI) 3 4 4 dbSNP (NCBI) dbSNP (NCBI) dbSNP (NCBI) 4 2 5 6 6 References 1 2 3 4 5 6 1 Gemmati D, Ongaro A, Scapoli GL, Della Porta M, Tognazzo S, Serino ML et al. Common gene polymorphisms in the metabolic folate and methylation pathway and the risk of acute lymphoblastic leukemia and non-Hodgkin's lymphoma in adults. Cancer Epidemiol Biomarkers Prev. 2004;13:787-794. O'Leary VB, Mills JL, Pangilinan F, Kirke PN, Cox C, Conley M et al. Analysis of methionine synthase reductase polymorphisms for neural tube defects risk association. Mol Genet Metab. 2005;85:220-227. Brody LC, Conley M, Cox C, Kirke PN, McKeever MP, Mills JL et al. A polymorphism, R653Q, in the trifunctional enzyme methylenetetrahydrofolate dehydrogenase/methenyltetrahydrofolate cyclohydrolase/formyltetrahydrofolate synthetase is a maternal genetic risk factor for neural tube defects: report of the Birth Defects Research Group. Am J Hum Genet. 2002;71:1207-1215. Skibola CF, Smith MT, Hubbard A, Shane B, Roberts AC, Law GR et al. Polymorphisms in the thymidylate synthase and serine hydroxymethyltransferase genes and risk of adult acute lymphocytic leukemia. Blood. 2002;99:3786-3791. Goto Y, Yue L, Yokoi A, Nishimura R, Uehara T, Koizumi S et al. A novel single-nucleotide polymorphism in the 3'untranslated region of the human dihydrofolate reductase gene with enhanced expression. Clin Cancer Res. 2001;7:1952-1956. Vesela K, Pavlikova M, Janosikova B, Andel M, Zvarova J, Hyanek J et al. Genetic determinants of folate status in Central Bohemia. Physiol Res. 2005;54:295-303. Minor allele frequency; MTR, 5-methyltetrahydrofolate-homocysteine methyltransferase (alias methionine synthase); 3 Single nucleotide database of National Center of Biotechnology (NCBI; www.ncbi.nlm.nih.gov); 4 MTRR, 5-methylenetetrahydrofolate-homocysteine methyltransferase reductase (alias methionine synthase reductase); 5 MTHFD1, 5,10-methylenetetrahydrofolate dehydrogenase; 6 TYMS, Thymidylate synthase; 7 2R and 3R are two and three 28-bp repeats in the 5’UTR of the TYMS gene, respectively; 8 Source: SNP500 database (Cancer Genome Anatomy Project, snp500cancer.nci.nih.gov ); 9 6-bp deletion in the 3’UTR of the TYMS gene; 10 SHMT1, serine hydroxymethyltransferase; 11 RFC1, reduced folate carrier; 12 DHFR, dihydrofolate reductase; 13 FOLR1, folate receptor 2